Health
Oxford begins first-of-its-kind trial study to reinfect recovered Coronavirus patients – Republic TV
Oxford to begin its first study of reinfecting recovered patients with the virus. Researchers are looking for 64 healthy, previously Covid-infected volunteers
As Oxford begins its first-of-its-kind trial study that may help to shed light on how to develop a more effective vaccine against the Coronavirus infection, people who have fought off with the COVID-19 virus will be deliberately reinfected. The UK University on Monday said that the researchers are looking for 64 healthy, previously COVID-19 infected volunteers from 18 to 30 years of age to be studied under controlled, quarantine conditions for at least 17 days. Participants will be infected with…
-
General10 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General24 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
General16 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Business22 hours agoWhy this speculative ASX stock is jumping 6% today